22 May 2015

Klaricid XL (Clarithromycin) - United Kingdom

Klaricid XL tablets

Generic Matches for Clarithromycin (3)
Klaricid 500mg tablets
Klaricid Adult Sachet
Klaricid Paediatric Suspension

Last Updated on 22 May 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Klaricid XL tablets Indication

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Klaricid XL 500 mg Tablets are indicated in adults and children 12 years and older.

Klaricid XL 500 mg Tablets is indicated for treatment of infections caused by susceptible organisms. Indications include:

Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia.

Upper respiratory tract infections for example, sinusitis and pharyngitis.

Klaricid XL 500 mg Tablets is also indicated in skin and soft tissue infections of mild to moderate severity, for example folliculitis, cellulitis and erysipelas.


Klaricid XL tablets Generic Name




Summary Product Characteristics (SPCs) Links
SPC - Klaricid XL 500 mg Tablets (external site)

Related Learning Zones

CSU Knowledge Centre and CME

CSU Knowledge Centre and CME

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In the Knowledge Centre, you will find a disease overview, symposium highlights platform, video channel and additional resources including an events calendar and useful external links. This resource has been given a whole new look and feel, intended to improve accessibility and visual appeal. Recent content additions include a frequently asked questions section, case studies from urticaria experts Professor Christian Vestergaard and Professor Torsten Zuberbier and information on the TARGET My Hives app.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Klaricid XL Marketing Information

Klaricid XL Generic Name
Marketing Company
Abbott Laboratories Limited
Drug Type
Date of Issue, Marketing Authority 01/12/1996

Related Drugs - Infectious Diseases

Back to top